Navigation Links
Best Practice Database Supports Chemistry, Manufacturing & Controls (CMC) Operations
Date:2/5/2009

CHAPEL HILL, N.C., Feb. 5 /PRNewswire/ -- Best Practices, LLC recently completed a new study to better understand resource and investment levels, expertise, and activities in global (pre-launch) Chemistry, Manufacturing and Control (CMC) operations in top pharmaceutical companies. This data-rich study provides numerous operational benchmarks around CMC facilities in terms of number/geographic locations, types of CMC activity performed, and FTEs by function and advanced degrees. The research also delivers benchmarks around number of projects, batches processed and timeframes for CMC activities. Other topic areas include capabilities & expertise and performance & measures. This study is intended to provide executives with data to assess the effectiveness and efficiency of their CMC operations and provide insights to improve drug development programs.

To view the study abstract or complimentary summary of the full report "Pharmaceutical Science Excellence: CMC Activities, Resources, and Performance," click on the following link http://www3.best-in-class.com/de612.htm.

In a benchmarking study that included such influential companies as Abbott, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis and Pfizer, many key topics were covered, including:

     * Scope of Operations
     * Activities
     * Facilities
     * Resources and Education Levels
     * Outputs and Development Timeframes
     * Capabilities & Expertise
     * Performance and Measures
     * Efficiency Ratios
     * Lessons Learned


    Among the key topics gathered in this report are:

     * Percent of Activities Outsourced
     * Number of Labs/Plants
     * Type of Labs/Plants
     * Location of Labs/Plants
     * CMC FTE Data
     * Percent of FTEs Located at Central R&D Location
     * Percentage of FTEs in Each CMC Function
     * Percentage of FTEs with Advanced Degrees
     * Number of Drug Development Projects
     * Number of CMC Batches
     * Percentage of Work Completed by CMOs
     * Number of CMOs Used
     * CMC Development Timeframes
     * Organizational Capabilities
     * CMC Performance Measures

For more information on this report, contact Ben Gregory at bgregory@best-in-class.com or (919) 767-9160. To access the full report or download a complimentary copy of the report summary, go to http://www3.best-in-class.com/de612.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more than 15 years, our highly credentialed research staff has conducted primary research exclusively for our Fortune 500 client base.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PracticeMatch: Healthcare Survey Defines Physician Recruitment Challenges
2. New Study Provides Benchmarks for Best Practices for Valuing Internal Consulting Organizations
3. Medical Marketing Firm Builds Service Provider and Medical Practice Bottom Lines
4. American College of Medical Genetics Foundation Unveils New Website: ACMG Foundation Supports Medical Genetics Research, Education and Practice
5. Radiologists overestimate their overall risk of malpractice lawsuits in breast imaging
6. EDI Health Group Selected by Quality Systems to Facilitate EDI Transactions Between Payers and Large Dental Group Practices
7. Applying the Obama Test to Healthcare: SimplyWell Cited as Top 10 Best Practices by Center for Healthcare Transformation
8. World-renowned Instructor of the Healing Practice of Qigong to Teach in Los Angeles Mar. 7 & 8
9. Alliance of Experts Created to Help Raise Awareness of Best Practices in Diabetes Treatment
10. Nationally Recognized Medicaid Fraud Prosecutor Tim Terry Joins Successful Whistleblower Law Practice, Specializing in "Qui Tam" Citizen Suits Under False Claims Acts
11. Most inactive physicians retain licenses, return to practice without competency review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... San Fernando Valley, CA (PRWEB) , ... December 07, 2016 , ... ... Sculptra can be used in several ways to restore a more youthful appearance to ... doctors , now offer Sculptra, along with a variety of other treatments, to rejuvenate ...
(Date:12/7/2016)... ... ... They are musicians and librarians, fashion designers and fitness instructors, actors, athletes ... and around the nation. What do they have in common? All have been affected ... compelling new photographic exhibit debuting Friday, December 9 at Logan International Airport in Boston. ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... financial consultation services from offices located in South Lyon, Dewitt, Williamston, East Lansing, ... a basketball coach who needs treatment for a brain tumor. , Jason Bauer ...
(Date:12/7/2016)... , ... December 07, 2016 , ... One of two ... of the securement tape is painful for her. "This is why the co-inventor and ... heads," she said. , They then created a prototype of the patent-pending AV-AIR, a ...
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, 2016 , ... ... new study entitled “Canine Filamentous Dermatitis Associated with Borrelia Infection” ... The study was published in the prestigious Journal of Veterinary Science & Medical ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- According to responses from U.S. oncologists that participated in ... with non-small cell lung cancer (NSCLC), treatment decisions are made ... status. The findings of the survey were presented today as ... ) at the 2016 World Conference on Lung Cancer (WCLC) ... survey results revealed an overall high rate of EGFR mutation ...
(Date:12/7/2016)... 7, 2016 Boehringer Ingelheim today announced ... with unresectable malignant pleural mesothelioma (MPM) met its ... presented at the 17 th IASLC World ... , showed nintedanib plus pemetrexed/cisplatin demonstrated a ... with a significantly improved PFS (9.4 vs 5.7 ...
(Date:12/7/2016)... , December 7, 2016 Today, Stock-Callers.com ... (NASDAQ: JAZZ ), Anthera Pharmaceuticals Inc. (NASDAQ: ... ), and AveXis Inc. (NASDAQ: AVXS ). From ... fell roughly 37% to reach a level equal to what ... down by approximately 14% for the year, it has still ...
Breaking Medicine Technology: